Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1”

10,559 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,559 results

Not applicableStudy completedNCT02280564
What this trial is testing

Study of A Cell-Phone System to Improve Health of Youth With Diabetes

Who this might be right for
Type 1 Diabetes
University of North Carolina, Chapel Hill 74
Not applicableLooking for participantsNCT07529704
What this trial is testing

Evaluation of a Multicomponent Early Intervention for Childhood Obesity Prevention in Vulnerable Families

Who this might be right for
Obesity & OverweightVulnerable FamiliesChildren+1 more
Helena Vall Roqué 526
Not applicableStudy completedNCT00811317
What this trial is testing

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Boston University Charles River Campus 11
Early research (Phase 1)Study completedNCT00697632
What this trial is testing

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 180
Early research (Phase 1)Study completedNCT05262387
What this trial is testing

LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 25
Not applicableStudy completedNCT02320084
What this trial is testing

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care

Who this might be right for
Hereditary Tyrosinemia, Type I
Swedish Orphan Biovitrum 315
Testing effectiveness (Phase 2)Study completedNCT01969747
What this trial is testing

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

Who this might be right for
Diabetes Mellitus, Type 1
Boehringer Ingelheim 75
Not applicableStudy completedNCT02812498
What this trial is testing

Teleconsultation in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Niguarda Hospital 150
Not applicableStudy completedNCT00105352
What this trial is testing

Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 120
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Early research (Phase 1)Looking for participantsNCT04234048
What this trial is testing

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more
SciTech Development, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00244855
What this trial is testing

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

Who this might be right for
Contiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Marginal Zone Lymphoma+20 more
Fred Hutchinson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT01053078
What this trial is testing

Naltrexone and Hypoglycemia in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia Unawareness
University of Minnesota 29
Testing effectiveness (Phase 2)Study completedNCT00244985
What this trial is testing

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Roswell Park Cancer Institute 42
Not applicableStudy completedNCT00482443
What this trial is testing

Assessing the Effectiveness of Diabetes Interactive Diary (DID) in Diabetes Management

Who this might be right for
Type 1 Diabetes Mellitus
The Royal Bournemouth Hospital 20
Not applicableWithdrawnNCT01886625
What this trial is testing

Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)

Who this might be right for
Complex Regional Pain Syndrome Type I of the Upper Limb
University of Groningen
Testing effectiveness (Phase 2)Study completedNCT00720876
What this trial is testing

Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT03011814
What this trial is testing

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

Who this might be right for
Folliculotropic Mycosis FungoidesRecurrent Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides+5 more
City of Hope Medical Center 78
Early research (Phase 1)Study completedNCT02065752
What this trial is testing

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Who this might be right for
Healthy Volunteers
Janssen Research & Development, LLC 2
Not applicableStudy completedNCT05152121
What this trial is testing

Additional Insulin for High Fat/Protein in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesAdolescent
Ege University 20
Next Page